WHO drops hydroxychloroquine from Covid-19 clinical trial
The World Health Organization on Wednesday said it was dropping the malaria medicine hydroxychloroquine from its massive study investigating treatments for the coronavirus, after available data indicated the drug was not effective for Covid-19.
The announcement from the agency is the latest blow to the hopes that hydroxychloroquine, as well as the related drug chloroquine, could provide patients an option at a time when there are too few treatments available for the virus. Those hopes were fanned by President Trump and some of his political allies, who vowed the drug could be a game changer despite a dearth of evidence indicating they worked.
Read Original Article: WHO drops hydroxychloroquine from Covid-19 clinical trial »
